Why the study?
Does vanadium treatment reduce blood pressure and alter angiotensin II and endothelin-1 levels in sucrose-fed spontaneously hypertensive rats?
Does vanadium treatment reduce blood pressure and alter angiotensin II and endothelin-1 levels in sucrose-fed spontaneously hypertensive rats?
Vanadium therapy reverses sucrose-induced hypertension and elevated angiotensin II levels in spontaneously hypertensive rats, suggesting a role for the renin-angiotensin system in this model.
Should not change clinical hypertension practice; hypothesis-generating for vanadium effects on renin-angiotensin and endothelin pathways in metabolic models.
OBJECTIVE: To determine the changes in serum angiotensin II (Ang II) and endothelin-1 levels induced by vanadium treatment of sugar-fed rats in order to investigate the relationship between changes in blood pressure and Ang II and endothelin-1 levels. METHODS: Male spontaneously hypertensive rats (SHR) were fed starch (control), sucrose, and sucrose plus vanadium compounds at various concentrations. The systolic blood pressure of the rats was estimated by tail-cuff plethysmography. Serum Ang II and endothelin-1 levels were measured by radioimmunoassay. RESULTS: There were increases in systolic blood pressure (by 8%) and in serum Ang II (by 20%) in sucrose-fed SHR compared with control. In sucrose plus vanadium-fed SHR, the lowering of the systolic blood pressure (by 11-16% of the sucrose-fed value) was accompanied by a significant decrease in Ang II levels (by 25-60% of the sucrose-fed value) and an increase in endothelin-1 level (by 61-76% of the sucrose-fed value). CONCLUSION: That Ang II levels are elevated in sucrose-induced hypertension and decreased after vanadium therapy suggests that the renin-angiotensin system plays a role in the induction of hypertension in this model. On the other hand, the elevation of endothelin-1 levels associated with a decreased systolic blood pressure might be secondary to vanadium stimulation of endothelial cells. The data suggest that endothelin-1 is not involved in sugar-induced elevations of the blood pressure.
No takes yet. Share an insight, caveat, or question.
Shi et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: